Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid

Alice Moussy (1) , Nan Papili Gao , Guillaume Corre (1) , Valentina Poletti (2) , Saliha Majdoul (1) , David Fenard (3) , Rudiyanto Gunawan , Daniel Stockholm (3) , Andràs Paldi (4)

1 INTEGRARE - Approches génétiques intégrées et nouvelles thérapies pour les maladies rares
2 UNIMORE - Università degli Studi di Modena e Reggio Emilia = University of Modena and Reggio Emilia
3 Généthon
4 I-STEM - Institut des cellules souches pour le traitement et l'étude des maladies monogéniques

Domains: Life Sciences [q-bio]; Cellular Biology; Life Sciences [q-bio]; Biochemistry, Molecular Biology; Life Sciences [q-bio]; Quantitative Methods [q-bio.QM]; Life Sciences [q-bio]; Biotechnology; Life Sciences [q-bio]; Genetics; Life Sciences [q-bio]; Immunology

Alice Moussy, Nan Papili Gao, Guillaume Corre, Valentina Poletti, Saliha Majdoul, et al.. Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid. Human Gene Therapy, 2019, ⟨10.1089/hum.2019.009⟩. ⟨hal-02178315⟩